DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells

Journal of Biological Chemistry

Volumn 290, Issue 17, 2015, Pages 11108-11118

  Li, Tianliang ^a   Su, Ling ^a   Lei, Yuanjiu ^a   Liu, Xianfang ^a   Zhang, Yajing ^a   Liu, Xiangguo ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL ORGANS; CELL DEATH; CELL MEMBRANES; DISEASES; DNA; RESPIRATORY SYSTEM;

ANTICANCER DRUG; CELL SURFACE RECEPTORS; ENDOPLASMIC RETICULUM STRESS; HUMAN LUNG CANCER CELLS; PROMOTER ACTIVITIES; PROMOTER REGION; TRANSCRIPTIONAL REGULATION; TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGANDS;

BINDING SITES;

DEATH RECEPTOR 4; DEATH RECEPTOR 5; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HISTONE ACETYLTRANSFERASE; PHOSPHOPROTEIN; PROTEIN C JUN; PROTEIN KAT2A; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; DDIT3 PROTEIN, HUMAN; KAT2A PROTEIN, HUMAN; TNFRSF10A PROTEIN, HUMAN; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTOR CHOP;

EID: 84928393460     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.645333     Document Type: Article

References (51)

1. Ashkenazi, A. (2008) Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat. Rev. Drug Discov. 7, 1001-1012
2. Ashkenazi, A., and Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308
3. Tsai, J. Y., Hung, C. M., Bai, S. T., Huang, C. H., Chen, W. C., Chung, J. G., Kuo, S. C., Way, T. D., and Huang, L. J. (2010) Induction of apoptosis by HAC-Y6, a novel microtubule inhibitor, through activation of the death receptor 4 signaling pathway in human hepatocellular carcinoma cells. Oncol. Rep. 24, 1169-1178
4. Jin, X., Wu, X. X., Abdel-Muneem Nouh, M. A., and Kakehi, Y. (2007) Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin. J. Urol. 177, 1894-1899
5. Lee, B. S., Cha, H. Y., Shin, Y. S., Kim, Y. S., and Kim, C. H. (2013) AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation. Endocr. Relat. Cancer 20, 283-291
6. Lim, J. H., Park, J. W., Choi, K. S., Park, Y. B., and Kwon, T. K. (2009) Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC δ-independent mechanism in human malignant tumor cells. Carcinogenesis 30, 729-736
7. Elrod, H. A., and Sun, S. Y. (2008) Modulation of death receptors by cancer therapeutic agents. Cancer Biol. Ther. 7, 163-173
8. Sun, S. Y. (2005) Chemopreventive agent-induced modulation of death receptors. Apoptosis 10, 1203-1210
9. Thorburn, A. (2004) Death receptor-induced cell killing. Cell. Signal. 16, 139-144
10. Guan, B., Yue, P., Lotan, R., and Sun, S. Y. (2002) Evidence that the human death receptor 4 is regulated by activator protein 1. Oncogene 21, 3121-3129
11. Liu, X., Yue, P., Khuri, F. R., and Sun, S. Y. (2004) p53 upregulates death receptor 4 expression through an intronic p53 binding site. Cancer Res. 64, 5078-5083
12. Mendoza, F. J., Ishdorj, G., Hu, X., and Gibson, S. B. (2008) Death receptor-4 (DR4) expression is regulated by transcription factor NF-κB in response to etoposide treatment. Apoptosis 13, 756-770
13. Wu, G. S., Burns, T. F., McDonald, E. R., 3rd, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and el-Deiry, W. S. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17, 141-143
14. Takimoto, R., and El-Deiry, W. S. (2000) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19, 1735-1743
15. Ravi, R., Bedi, G. C., Engstrom, L. W., Zeng, Q., Mookerjee, B., Gélinas, C., Fuchs, E. J., and Bedi, A. (2001) Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB. Nat. Cell Biol. 3, 409-416
16. Shetty, S., Graham, B. A., Brown, J. G., Hu, X., Vegh-Yarema, N., Harding, G., Paul, J. T., and Gibson, S. B. (2005) Transcription factor NF-κB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol. Cell. Biol. 25, 5404-5416
17. Baritaki, S., Katsman, A., Chatterjee, D., Yeung, K. C., Spandidos, D. A., and Bonavida, B. (2007) Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J. Immunol. 179, 5441-5453
18. Yamaguchi, H., and Wang, H. G. (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 279, 45495-45502
19. Yoshida, T., Shiraishi, T., Nakata, S., Horinaka, M., Wakada, M., Mizutani, Y., Miki, T., and Sakai, T. (2005) Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein. Cancer Res. 65, 5662-5667
20. Li, J., Lee, B., and Lee, A. S. (2006) Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J. Biol. Chem. 281, 7260-7270
21. Puthalakath, H., O'Reilly, L. A., Gunn, P., Lee, L., Kelly, P. N., Huntington, N. D., Hughes, P. D., Michalak, E. M., McKimm-Breschkin, J., Motoyama, N., Gotoh, T., Akira, S., Bouillet, P., and Strasser, A. (2007) ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129, 1337-1349
22. Upton, J. P., Austgen, K., Nishino, M., Coakley, K. M., Hagen, A., Han, D., Papa, F. R., and Oakes, S. A. (2008) Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress. Mol. Cell. Biol. 28, 3943-3951
23. Cazanave, S. C., Elmi, N. A., Akazawa, Y., Bronk, S. F., Mott, J. L., and Gores, G. J. (2010) CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G236-G243
24. Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H., Stevens, J. L., and Ron, D. (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982-995
25. Pino, S. C., O'Sullivan-Murphy, B., Lidstone, E. A., Yang, C., Lipson, K. L., Jurczyk, A., diIorio, P., Brehm, M. A., Mordes, J. P., Greiner, D. L., Rossini, A. A., and Bortell, R. (2009) CHOP mediates endoplasmic reticulum stress-induced apoptosis in Gimap5-deficient T cells. PLoS One 4, e5468
26. Fonseca, S. G., Gromada, J., and Urano, F. (2011) Endoplasmic reticulum stress and pancreatic beta cell death. Trends Endocrinol. Metab. 22, 266-274
27. Averous, J., Bruhat, A., Jousse, C., Carraro, V., Thiel, G., and Fafournoux, P. (2004) Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J. Biol. Chem. 279, 5288-5297
28. Ubeda, M., Wang, X. Z., Zinszner, H., Wu, I., Habener, J. F., and Ron, D. (1996) Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol. Cell. Biol. 16, 1479-1489
29. Liu, X., Yue, P., Zhou, Z., Khuri, F. R., and Sun, S. Y. (2004) Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J. Natl. Cancer Inst. 96, 1769-1780
30. Lu, M., Lawrence, D. A., Marsters, S., Acosta-Alvear, D., Kimmig, P., Mendez, A. S., Paton, A. W., Paton, J. C., Walter, P., and Ashkenazi, A. (2014) Cell death: opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science 345, 98-101
31. Marmorstein, R., and Roth, S. Y. (2001) Histone acetyltransferases: function, structure, and catalysis. Curr. Opin. Genet. Dev. 11, 155-161
32. Miyagi, S., Mishima, Y., and Iwama, A. (2011) [Structure and function of MYST family histone acetyltransferases]. Rinsho ketsueki 52, 490-496
33. Jin, Q., Yu, L. R., Wang, L., Zhang, Z., Kasper, L. H., Lee, J. E., Wang, C., Brindle, P. K., Dent, S. Y., and Ge, K. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J. 30, 249-262
34. Gunderson, F. Q., and Johnson, T. L. (2009) Acetylation by the transcriptional coactivator Gcn5 plays a novel role in co-transcriptional spliceosome assembly. PLoS Genet. 5, e1000682
35. Chérasse, Y., Maurin, A. C., Chaveroux, C., Jousse, C., Carraro, V., Parry, L., Deval, C., Chambon, C., Fafournoux, P., and Bruhat, A. (2007) The p300/CBP-associated factor (PCAF) is a cofactor of ATF4 for amino acid-regulated transcription of CHOP. Nucleic Acids Res. 35, 5954-5965
36. Ohoka, N., Hattori, T., Kitagawa, M., Onozaki, K., and Hayashi, H. (2007) Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portion. J. Biol. Chem. 282, 35687-35694
37. Sun, S. Y., Liu, X., Zou, W., Yue, P., Marcus, A. I., and Khuri, F. R. (2007) The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells. J. Biol. Chem. 282, 18800-18809
38. Yoshida, T., Shiraishi, T., Horinaka, M., Wakada, M., and Sakai, T. (2007) Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin. Oncol. Rep. 18, 1239-1242
39. Verfaillie, T., Garg, A. D., and Agostinis, P. (2013) Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett. 332, 249-264
40. Downey, M., Knight, B., Vashisht, A. A., Seller, C. A., Wohlschlegel, J. A., Shore, D., and Toczyski, D. P. (2013) Gcn5 and sirtuins regulate acetylation of the ribosomal protein transcription factor Ifh1. Curr. Biol. 23, 1638-1648
41. Sterner, D. E., and Berger, S. L. (2000) Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64, 435-459
42. Johnsson, A., Durand-Dubief, M., Xue-Franzén, Y., Rönnerblad, M., Ekwall, K., and Wright, A. (2009) HAT-HDAC interplay modulates global histone H3K14 acetylation in gene-coding regions during stress. EMBO Rep. 10, 1009-1014
43. Liu, G., Su, L., Hao, X., Zhong, N., Zhong, D., Singhal, S., and Liu, X. (2012) Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells. J. Cell. Mol. Med. 16, 1618-1628
44. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., and Ron, D. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664-666
45. Shaulian, E., and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136
46. Zhang, W., Bone, J. R., Edmondson, D. G., Turner, B. M., and Roth, S. Y. (1998) Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J. 17, 3155-3167
47. Suka, N., Suka, Y., Carmen, A. A., Wu, J., and Grunstein, M. (2001) Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol. Cell 8, 473-479
48. Marmorstein, R. (2001) Structure of histone acetyltransferases. J. Mol. Biol. 311, 433-444
49. Yang, A., Wilson, N. S., and Ashkenazi, A. (2010) Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. Curr. Opin. Cell Biol. 22, 837-844
50. Kimberley, F. C., and Screaton, G. R. (2004) Following a TRAIL: update on a ligand and its five receptors. Cell Res. 14, 359-372
51. Liu, X., Yue, P., Chen, S., Hu, L., Lonial, S., Khuri, F. R., and Sun, S. Y. (2007) The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res. 67, 4981-4988